Engineers Gate Manager LP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 220 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 4.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Engineers Gate Manager LP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$427,365
-41.0%
15,686
-51.8%
0.02%
-40.7%
Q2 2023$724,527
+20.6%
32,563
+10.1%
0.03%
-25.0%
Q4 2022$600,628
+96.3%
29,573
+117.8%
0.04%
+200.0%
Q1 2022$306,000
-29.0%
13,577
-37.6%
0.01%
-36.8%
Q4 2021$431,000
+8.6%
21,766
+20.6%
0.02%
-26.9%
Q2 2021$397,000
+7.3%
18,045
+16.1%
0.03%
+44.4%
Q1 2021$370,000
-49.2%
15,537
-44.3%
0.02%
-43.8%
Q4 2020$729,000
-18.0%
27,874
-47.2%
0.03%
-28.9%
Q2 2020$889,000
+45.7%
52,827
+3.0%
0.04%
+2.3%
Q1 2020$610,000
-64.3%
51,275
-63.7%
0.04%
-41.3%
Q4 2019$1,707,000
+378.2%
141,113
+458.1%
0.08%
+316.7%
Q3 2019$357,000
-56.8%
25,283
-65.9%
0.02%
-60.9%
Q2 2019$827,000
-44.6%
74,162
-41.7%
0.05%
-48.9%
Q1 2019$1,493,000
+113.0%
127,169
+142.3%
0.09%
+60.7%
Q4 2018$701,000
+15.3%
52,483
+21.1%
0.06%
+19.1%
Q3 2018$608,000
+185.4%
43,339
+220.6%
0.05%
+176.5%
Q2 2018$213,000
-86.2%
13,520
-84.2%
0.02%
-84.0%
Q4 2017$1,547,00085,6540.11%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders